Losmapimod
id:
losmapimod-224-4458959
title:
Losmapimod
text:
Losmapimod (GW856553X) is an investigational drug that reached stage III clinical trials for multiple medical conditions, but did not prove efficacy. It was most recently in development by Fulcrum Therapeutics for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Losmapimod selectively inhibits enzymes p38α/β mitogen-activated protein kinases (MAPKs), which are modulators of DUX4 expression and mediators of inflammation.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Losmapimod
date created:
2009-11-02T09:15:42Z
date modified:
2024-09-14T14:37:37Z
main entity:
{"identifier":"Q6683687","url":"https://www.wikidata.org/entity/Q6683687"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/ad/Losmapimod.svg","width":714,"height":351}
fields total:
13
integrity:
16